Japanese longitudinal biomarker study in progressive supranuclear palsy and corticobasal degeneration: Clinical features of the first registered patients and short-term follow-up analysis

Highlights • Japanese study collects data samples from 349 patients across 45 sites since 2014.• Examining PSP/CBS patients’ initial symptoms, revealing differences among subtypes.• PSPRS score and mortality of CBS patients are severe among the subtypes.• Cognitive dysfunction may be a predictive factor of disease severity and progression.

• Publication year

  2024

• Venue

  Clinical Parkinsonism & Related Disorders

• Publication date

  2024-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.prdoa.2024.100279PMID 39534091PMCID 11554922
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical course of pathologically confirmed corticobasal degeneration and corticobasal syndrome

  2023influential reference
• DescribePSP and ProPSP: German Multicenter Networks for Standardized Prospective Collection of Clinical Data, Imaging Data, and Biomaterials of Patients With Progressive Supranuclear Palsy

  2021cited by this paper
• A Modified Progressive Supranuclear Palsy Rating Scale

  2021cited by this paper
• A Convenient Prognostic Tool and Staging System for Progressive Supranuclear Palsy

  2020cited by this paper
• Sensitivity and Specificity of Diagnostic Criteria for Progressive Supranuclear Palsy

  2019cited by this paper
• Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome

  2019cited by this paper
• Progressive Supranuclear Palsy with Predominant Cerebellar Ataxia

  2019cited by this paper
• Predictors of survival in progressive supranuclear palsy and multiple system atrophy: a systematic review and meta-analysis

  2017cited by this paper
• Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria

  2017cited by this paper
• Progressive supranuclear palsy: progression and survival

  2016cited by this paper
• Predicting disease progression in progressive supranuclear palsy in multicenter clinical trials.

  2016influential reference
• Validation of the new consensus criteria for the diagnosis of corticobasal degeneration

  2014influential reference
• The phenotypic spectrum of progressive supranuclear palsy: A retrospective multicenter study of 100 definite cases

  2014influential reference
• Rate of decline in progressive supranuclear palsy

  2014influential reference
• Clinical outcomes of two main variants of progressive supranuclear palsy and multiple system atrophy: a prospective natural history study

  2014cited by this paper
• Accuracy of the national institute for neurological disorders and stroke/society for progressive supranuclear palsy and neuroprotection and natural history in Parkinson plus syndromes criteria for the diagnosis of progressive supranuclear palsy

  2013cited by this paper
• Criteria for the diagnosis of corticobasal degeneration

  2013cited by this paper
• Predictors of survival in a series of clinically diagnosed progressive supranuclear palsy patients.

  2013cited by this paper
• Diagnostic criteria for corticobasal syndrome: a comparative study

  2011cited by this paper
• Cerebellar involvement in progressive supranuclear palsy: A clinicopathological study

  2009cited by this paper
• Pure akinesia with gait freezing: A third clinical phenotype of progressive supranuclear palsy

  2007cited by this paper
• A clinical rating scale for progressive supranuclear palsy.

  2007influential reference
• [Prognosis of patients with progressive supranuclear palsy].

  2005influential reference
• A comparison of the Barthel Index and the Functional Independence Measure as outcome measures in stroke rehabilitation: patterns of disability scale usage in clinical trials

  2005cited by this paper
• Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.

  2005influential reference
• Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome

  2005cited by this paper
• Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia

  2003cited by this paper
• Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination

  1998influential reference
• Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome)

  1996cited by this paper
• Corticodentatonigral degeneration with neuronal achromasia.

  1968cited by this paper
• Progressive Supranuclear Palsy: A Heterogeneous Degeneration Involving the Brain Stem, Basal Ganglia and Cerebellum With Vertical Gaze and Pseudobulbar Palsy, Nuchal Dystonia and Dementia

  1964cited by this paper

• Frequency of anti-IgLON5 disease in patients with a typical clinical presentation of progressive supranuclear palsy/corticobasal syndrome.

  2025cites this paper
• Progressive Supranuclear Palsy-A Global Review.

  2025cites this paper